transparency
EMA in turmoil as top job ‘annulled’
November 17, 2014Sales and Marketing EC, EMA, EU, Europe, Guido Rasi, Rasi, transparency
The future of Guido Rasi, head of Europe’s drugs regulator, is up in the air after a legal ruling which …
EMA responds to redaction concerns
November 14, 2014Sales and Marketing AbbVie, EMA, Goldacre, Humira, Rasi, adalimumab, redactions, transparency
The EMA has published a response to European Ombudsman Emily O’Reilly’s questions about some of its trial data redactions. O’Reilly’s …
Pharma and transparency: actions speak louder than words
October 13, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, UK, alltrials, andrew powrie-smith, hcp, transparency
As an industry we continue to deliver innovative, life changing medicines and rewrite the story of many diseases, yet our …
Mixed response to EMA data transparency plans
October 3, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, BMJ, Ben Goldacre, EMA, alltrials, transparency
The European Medicines Agency has passed new rules that will mandate pharma to release more of its clinical trial data …
NHS launches transparency website
September 23, 2014Medical Communications, Sales and Marketing NHS, NHS England, mynhs, transparency, website
NHS England has launched a new ‘comparison website tool’ that allows health and social care organisations to see how their …
NICE seeks more trial data from pharma
September 10, 2014Medical Communications, Research and Development, Sales and Marketing David Haslam, NICE, Tamiflu, alltrials, transparency
NICE is calling on pharma to release more data so it can better assess the costs of new medicines.The watchdog …
Janssen: why transparency is essential to the health of our industry
August 29, 2014Medical Communications, Research and Development, Sales and Marketing EFPIA, EMEA, Goldacre, Janssen, alltrials, transparency
The pharmaceutical industry is moving forward, working together to ensure patients have access to new and innovative medicines.However, more must …
Publish all clinical trials, say pharma doctors
August 29, 2014Research and Development, Sales and Marketing Goldacre, all trials, data, fpm, transparency
All clinical trials should be registered and published according to a recent survey conducted by the Faculty of Pharmaceutical Medicine. …
EMA delays trial transparency – again
July 10, 2014Medical Communications, Research and Development, Sales and Marketing EMA, Goldacre, Rasi, alltrials, clinical trials, transparency
The European Medicines Agency has once again said that it is to delay the launch of its new clinical trial …
BMS expands data transparency
June 27, 2014Medical Communications, Sales and Marketing BMS, best electronic cigarettes, csr, dcri, transparency
Bristol-Myers Squibb is to expand access to its clinical trial data – but researchers’ requests will have to be approved …
Data authority chair calls for pharma transparency
June 24, 2014Medical Communications, Sales and Marketing HSCIC, NHS, care data, care.data, manning, transparency
The chair of the UK’s national healthcare information provider says that government and industry have “a lot of work to …
EMA changes ‘on screen’ data policy
June 16, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Goldacre, Humira, alltrials, transparency
The European Medicines Agency is to formally agree its policy on the vexed issue of the publication of clinical trial …
Lilly the latest to open up data
June 4, 2014Medical Communications, Research and Development, Sales and Marketing Goldacre, NHS, alltrials, data, lilly, transparency, trials
Eli Lilly is to begin sharing its clinical trial data with scientific researchers through a website housing information from several …
BMJ slams EMA ‘U-turn’
May 30, 2014Medical Communications, Research and Development, Sales and Marketing BMJ, EMA, alltrials, data, transparency
The BMJ has attacked the European Medicines Agency for what it believes is a decision to ‘backtrack’ on public access …
Boehringer launches new transparency regime
May 12, 2014Research and Development, Sales and Marketing Boehringer, LEO Pharma, all trials, csr, transparency
Boehringer is making good on its 2013 promise to release more clinical trial data to researchers with the launch of …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
